Revolutionizing the Way We Treat Heart Failure
Heart failure kills more people globally than any other ailments, yet there is no ultimate treatment for the condition. Our goal is to develop and commercialize an effective and reasonably-priced therapy for heart failure using a specific fibroblast cells we call “VCF”, that we obtain from the patient’s own heart.
Our approach to heart failure therapy is quite different from other technologies in a sense that we do not want to replace what is “broken”, but rather we want to repair the damage by enhancing the cells’ own ability to heal.
Location: Japan, Kawasaki
Employees: 11-50
Total raised: $30.8M
Investors 6
| Date | Name | Website |
| - | Sony Innov... | sonyinnova... |
| - | MAKOTO CAP... | mkto-capit... |
| 16.02.2021 | The Univer... | ut-ec.co.j... |
| - | Beyond Nex... | beyondnext... |
| - | Eight Road... | eightroads... |
| - | J-Startup | j-startup.... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 29.06.2022 | Series C | $14M | - |
| 04.01.2021 | Series B | $12.8M | - |
| 20.05.2020 | Series B | $4M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 05.07.2022 | Metcela Closes $14M Series C Financing | Metcela, a Kanagawa, Japan-based clinical-stage biotechnology company developing first-in-class auto... | finsmes.co... |
| 29.06.2022 | Metcela Inc. Completes the Series C Financing of Total $14 M... | KANAGAWA, Japan (PRWEB) June 29, 2022 Metcela, a clinical-stage biotechnology company developing fi... | prweb.com/... |
| 04.01.2021 | Metcela Inc. announced that it has received ¥1.32 billion in... | On January 4, 2021, Metcela Inc. closed the transaction. The company amended the terms of the transa... | marketscre... |
| 04.01.2021 | Metcela Secures $12.7 Million Series B Financing to Initiate... | KANAGAWA, Japan (PRWEB) January 04, 2021 Metcela is a clinical-stage Kanagawa-based biotech company... | prweb.com/... |
| 04.01.2021 | Metcela Raises $12.7M in Series B Financing | Metcela, a Kanagawa, Japan-based clinical-stage biotech startup specializing in fibroblast-based cel... | finsmes.co... |
| 20.05.2020 | Metcela Raises $4M in Series B Funding | Metcela Inc., a Tsuruoka-shi, Yamagata, Japan-based biotech startup specializing in fibroblast-based... | finsmes.co... |
| 04.10.2019 | Tokyo-based Startup Secures $42.9M Series B To Diagnose Gast... | 16 Shares Email Facebook Twitter LinkedIn Tokyo-based AI Medical Service Inc., which is developing ... | news.crunc... |